Epitope mapping of 53 antibodies against prostate-specific antigen

Tumor Biology

Volumn 20, Issue SUPPL. 1, 1999, Pages 18-23

  Bellanger, L ^a   Andres C ^a   Seguin, P ^a  

^a CIS Bio International   (France)

Author keywords

Biacore; Epitopes; Prostate specific antigen

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1A5 6; MONOCLONAL ANTIBODY 2E9; MONOCLONAL ANTIBODY 2H11; MONOCLONAL ANTIBODY 4H5; MONOCLONAL ANTIBODY 5A10; MONOCLONAL ANTIBODY 92 284 3; MONOCLONAL ANTIBODY 93 251; MONOCLONAL ANTIBODY 94 6102; MONOCLONAL ANTIBODY 9B10; MONOCLONAL ANTIBODY E72; MONOCLONAL ANTIBODY E74; MONOCLONAL ANTIBODY E86; MONOCLONAL ANTIBODY E87; MONOCLONAL ANTIBODY E91; MONOCLONAL ANTIBODY F5; MONOCLONAL ANTIBODY H117; MONOCLONAL ANTIBODY H50; MONOCLONAL ANTIBODY M704; MONOCLONAL ANTIBODY MM1; MONOCLONAL ANTIBODY MP2; MONOCLONAL ANTIBODY PR1; MONOCLONAL ANTIBODY PR12; MONOCLONAL ANTIBODY PS101; MONOCLONAL ANTIBODY PS80; MONOCLONAL ANTIBODY PS98; MONOCLONAL ANTIBODY PSR217; MONOCLONAL ANTIBODY PSS233; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; BINDING AFFINITY; BIOSENSOR; CLASSIFICATION; CONFERENCE PAPER; EPITOPE MAPPING; IMMUNOREACTIVITY; IODINATION; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0032732286     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056525     Document Type: Conference Paper

References (11)

1. Wang MC, Valenzuela LA, Murphy GP, Chu TM: Purification of a human prostate specific antigen. Invest Urol 1979;17:159-163.
2. Lilja HA: Kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985;76:1899-1903.
3. Watt KW, Lee P-J, M'Timkulu T, Chan WP, Loor R: Human prostate specific antigen: Structural and functional similarity with serine proteases. Proc Natl Acad Sci USA 1986;83:3166-3170.
4. Lilja H, Oldbrink J, Rannevick G, Laurell CB: Seminal vesicle secreted proteins and their reactions during gelation and liquefaction of human semen. J Clin Invest 1987;80:281-285.
5. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317: 909-916.
6. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O: A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves the clinical sensitivity for cancer. Cancer Res 1991;51:222-226.
7. Christensson A, Björk T, Nilsson O, Dahlén U, Matikainen M, Cockett ATK, Abrahamsson P-A, Lilja H: Serum prostate-specific antigen complexed to alpha-1antichymotrypsin as an indicator of prostate cancer. J Urol 1993;150:100-105.
8. Yu H, Diamandis EP: Prostate-specific antigen in milk of lactating women. Clin Chem 1995;41:54-58.
9. Kamoshida S, Tsutsumi Y: Extraprostatic localization of prostate acid phosphatase and prostatic-specific antigen: Distribution in cloacogenic glandular epithelium and sex-dependent expression in human anal gland. Hum Pathol 1990;21: 1108-1111.
10. Iwakiri J, Grandbois K, Wehner N, Graves HCB, Stamey TA: An analysis of urinary prostatic-specific antigen before and after radical prostatectomy: Evidence for secretion of prostate-specific antigen by the periurethral glands. J Urol 1993;149: 783-786.
11. Pettersson K, Piironen T, Seppälä M, Liukkonen L, Christensson A, Matikainen M-T, Suonpää M, Lövgren T, Lilja H: Free and complexed prostate-specific antigen (PSA): In vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA α1-antichymotrypsin complex. Clin Chem 1995;41:1480-1488.